Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 95 entries
Sorted by: Best Match Show Resources per page
Molecular pathways associated with aggressiveness of papillary thyroid cancer.

Current genomics

Benvenga S, Koch CA.
PMID: 24955023
Curr Genomics. 2014 Jun;15(3):162-70. doi: 10.2174/1389202915999140404100958.

The most common thyroid malignancy is papillary thyroid cancer (PTC). Mortality rates from PTC mainly depend on its aggressiveness. Geno- and phenotyping of aggressive PTC has advanced our understanding of treatment failures and of potential future therapies. Unraveling molecular...

Cite
Benvenga S, Koch CA. Molecular pathways associated with aggressiveness of papillary thyroid cancer. Curr Genomics. 2014;15(3):162-70doi: 10.2174/1389202915999140404100958.
Benvenga, S., & Koch, C. A. (2014). Molecular pathways associated with aggressiveness of papillary thyroid cancer. Current genomics, 15(3), 162-70. https://doi.org/10.2174/1389202915999140404100958
Benvenga, Salvatore, and Koch, Christian A. "Molecular pathways associated with aggressiveness of papillary thyroid cancer." Current genomics vol. 15,3 (2014): 162-70. doi: https://doi.org/10.2174/1389202915999140404100958
Benvenga S, Koch CA. Molecular pathways associated with aggressiveness of papillary thyroid cancer. Curr Genomics. 2014 Jun;15(3):162-70. doi: 10.2174/1389202915999140404100958. PMID: 24955023; PMCID: PMC4064555.
Copy Download .nbib Format: NLM
Personalization of targeted therapy in advanced thyroid cancer.

Current genomics

Fallahi P, Ferrari SM, Mazzi V, Vita R, Benvenga S, Antonelli A.
PMID: 24955027
Curr Genomics. 2014 Jun;15(3):190-202. doi: 10.2174/1389202915999140404101902.

Although generally the prognosis of differentiated thyroid carcinoma (DTC) is good, approximately 5% of people are likely to develop metastases which fail to respond to radioactive iodine, and other traditional therapies, exhibiting a more aggressive behavior. Nowadays, therapy is...

Cite
Fallahi P, Ferrari SM, Mazzi V, et al. Personalization of targeted therapy in advanced thyroid cancer. Curr Genomics. 2014;15(3):190-202doi: 10.2174/1389202915999140404101902.
Fallahi, P., Ferrari, S. M., Mazzi, V., Vita, R., Benvenga, S., & Antonelli, A. (2014). Personalization of targeted therapy in advanced thyroid cancer. Current genomics, 15(3), 190-202. https://doi.org/10.2174/1389202915999140404101902
Fallahi, Poupak, et al. "Personalization of targeted therapy in advanced thyroid cancer." Current genomics vol. 15,3 (2014): 190-202. doi: https://doi.org/10.2174/1389202915999140404101902
Fallahi P, Ferrari SM, Mazzi V, Vita R, Benvenga S, Antonelli A. Personalization of targeted therapy in advanced thyroid cancer. Curr Genomics. 2014 Jun;15(3):190-202. doi: 10.2174/1389202915999140404101902. PMID: 24955027; PMCID: PMC4064559.
Copy Download .nbib Format: NLM
Molecular characterization and chromosomal localization of spermatogenesis related sequences in Torpedo torpedo (Chondrichthyes, Torpediniformes).

Marine genomics

Rocco L, Bencivenga S, Archimandritis A, Stingo V.
PMID: 21798177
Mar Genomics. 2009 Jun;2(2):99-102. doi: 10.1016/j.margen.2009.06.001. Epub 2009 Jun 25.

Cytogenetic data in cartilaginous fishes are currently very inconsistent, considering that the karyotype morphology of only about seventy living species is actually known. Only in the last few years different molecular approaches, first of all physical mapping on metaphase...

Cite
Rocco L, Bencivenga S, Archimandritis A, et al. Molecular characterization and chromosomal localization of spermatogenesis related sequences in Torpedo torpedo (Chondrichthyes, Torpediniformes). Mar Genomics. 2009;2(2):99-102doi: 10.1016/j.margen.2009.06.001.
Rocco, L., Bencivenga, S., Archimandritis, A., & Stingo, V. (2009). Molecular characterization and chromosomal localization of spermatogenesis related sequences in Torpedo torpedo (Chondrichthyes, Torpediniformes). Marine genomics, 2(2), 99-102. https://doi.org/10.1016/j.margen.2009.06.001
Rocco, Lucia, et al. "Molecular characterization and chromosomal localization of spermatogenesis related sequences in Torpedo torpedo (Chondrichthyes, Torpediniformes)." Marine genomics vol. 2,2 (2009): 99-102. doi: https://doi.org/10.1016/j.margen.2009.06.001
Rocco L, Bencivenga S, Archimandritis A, Stingo V. Molecular characterization and chromosomal localization of spermatogenesis related sequences in Torpedo torpedo (Chondrichthyes, Torpediniformes). Mar Genomics. 2009 Jun;2(2):99-102. doi: 10.1016/j.margen.2009.06.001. Epub 2009 Jun 25. PMID: 21798177.
Copy Download .nbib Format: NLM
LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy.

Frontiers in neuroscience

Fitch TE, Benvenga MJ, Jesudason CD, Zink C, Vandergriff AB, Menezes MM, Schober DA, Rorick-Kehn LM.
PMID: 24478625
Front Neurosci. 2014 Jan 28;8:5. doi: 10.3389/fnins.2014.00005. eCollection 2014.

We describe a novel, potent and selective orexin-2 (OX2)/hypocretin-2 receptor antagonist with in vivo activity in an animal model predictive of antidepressant-like efficacy. N-biphenyl-2-yl-4-fluoro-N-(1H-imidazol-2-ylmethyl) benzenesulfonamide HCl (LSN2424100) binds with high affinity to recombinant human OX2 receptors (Ki = 4.5...

Cite
Fitch TE, Benvenga MJ, Jesudason CD, et al. LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy. Front Neurosci. 2014;8:5doi: 10.3389/fnins.2014.00005.
Fitch, T. E., Benvenga, M. J., Jesudason, C. D., Zink, C., Vandergriff, A. B., Menezes, M. M., Schober, D. A., & Rorick-Kehn, L. M. (2014). LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy. Frontiers in neuroscience, 85. https://doi.org/10.3389/fnins.2014.00005
Fitch, Thomas E, et al. "LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy." Frontiers in neuroscience vol. 8 (2014): 5. doi: https://doi.org/10.3389/fnins.2014.00005
Fitch TE, Benvenga MJ, Jesudason CD, Zink C, Vandergriff AB, Menezes MM, Schober DA, Rorick-Kehn LM. LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy. Front Neurosci. 2014 Jan 28;8:5. doi: 10.3389/fnins.2014.00005. eCollection 2014. PMID: 24478625; PMCID: PMC3904085.
Copy Download .nbib Format: NLM
Intracranial Tumour Characterization: Whole Brain Evaluation with MR Perfusion Images and SPECT-CT.

The neuroradiology journal

Aprile I, Bencivenga S, Loreti F, Torni C.
PMID: 24059884
Neuroradiol J. 2011 Dec 30;24(6):838-45. doi: 10.1177/197140091102400602. Epub 2011 Dec 23.

A comparative study between perfusion magnetic resonance (MR) imaging and single photon emission tomography - computed tomography (SPECT-CT) was performed to disclose the indications and limits of the two techniques for brain tumour characterization. We compared these two techniques...

Cite
Aprile I, Bencivenga S, Loreti F, et al. Intracranial Tumour Characterization: Whole Brain Evaluation with MR Perfusion Images and SPECT-CT. Neuroradiol J. 2011;24(6):838-45doi: 10.1177/197140091102400602.
Aprile, I., Bencivenga, S., Loreti, F., & Torni, C. (2011). Intracranial Tumour Characterization: Whole Brain Evaluation with MR Perfusion Images and SPECT-CT. The neuroradiology journal, 24(6), 838-45. https://doi.org/10.1177/197140091102400602
Aprile, I, et al. "Intracranial Tumour Characterization: Whole Brain Evaluation with MR Perfusion Images and SPECT-CT." The neuroradiology journal vol. 24,6 (2011): 838-45. doi: https://doi.org/10.1177/197140091102400602
Aprile I, Bencivenga S, Loreti F, Torni C. Intracranial Tumour Characterization: Whole Brain Evaluation with MR Perfusion Images and SPECT-CT. Neuroradiol J. 2011 Dec 30;24(6):838-45. doi: 10.1177/197140091102400602. Epub 2011 Dec 23. PMID: 24059884.
Copy Download .nbib Format: NLM
Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis.

Journal of clinical & translational endocrinology

Benvenga S, Vita R, Di Bari F, Lo Re C, Scilipoti A, Giorgianni G, Grasso L, Galletti MR, Mandolfino MG, Le Donne M.
PMID: 31428563
J Clin Transl Endocrinol. 2019 Jul 24;18:100201. doi: 10.1016/j.jcte.2019.100201. eCollection 2019 Dec.

BACKGROUND: Measurement of serum thyroperoxidase autoantibodies (TPOAb) during gestation as a classical marker for the risk of postpartum thyroiditis (PPT) predicts PPT in 1/3 to 1/2 of women. Very few studies have measured serum thyroid hormone Ab (THAb) during...

Cite
Benvenga S, Vita R, Di Bari F, et al. Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis. J Clin Transl Endocrinol. 2019;18:100201doi: 10.1016/j.jcte.2019.100201.
Benvenga, S., Vita, R., Di Bari, F., Lo Re, C., Scilipoti, A., Giorgianni, G., Grasso, L., Galletti, M. R., Mandolfino, M. G., & Le Donne, M. (2019). Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis. Journal of clinical & translational endocrinology, 18100201. https://doi.org/10.1016/j.jcte.2019.100201
Benvenga, Salvatore, et al. "Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis." Journal of clinical & translational endocrinology vol. 18 (2019): 100201. doi: https://doi.org/10.1016/j.jcte.2019.100201
Benvenga S, Vita R, Di Bari F, Lo Re C, Scilipoti A, Giorgianni G, Grasso L, Galletti MR, Mandolfino MG, Le Donne M. Assessment of serum thyroid hormone autoantibodies in the first trimester of gestation as predictors of postpartum thyroiditis. J Clin Transl Endocrinol. 2019 Jul 24;18:100201. doi: 10.1016/j.jcte.2019.100201. eCollection 2019 Dec. PMID: 31428563; PMCID: PMC6693681.
Copy Download .nbib Format: NLM
Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature.

Case reports in cardiology

Acitelli A, Bencivenga S, Giannico MB, Lanzillo C, Maresca L, Petroni R, Penco M, Calò L, Romano S.
PMID: 31485355
Case Rep Cardiol. 2019 Aug 14;2019:5956806. doi: 10.1155/2019/5956806. eCollection 2019.

Coronary artery fistulas are rare abnormal connections between a coronary artery and a cardiac chamber or a major vessel. Often, they are asymptomatic and the diagnosis is accidental. The case we present is the incidental finding of a fistula...

Cite
Acitelli A, Bencivenga S, Giannico MB, et al. Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature. Case Rep Cardiol. 2019;2019:5956806doi: 10.1155/2019/5956806.
Acitelli, A., Bencivenga, S., Giannico, M. B., Lanzillo, C., Maresca, L., Petroni, R., Penco, M., Calò, L., & Romano, S. (2019). Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature. Case reports in cardiology, 20195956806. https://doi.org/10.1155/2019/5956806
Acitelli, Angelo, et al. "Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature." Case reports in cardiology vol. 2019 (2019): 5956806. doi: https://doi.org/10.1155/2019/5956806
Acitelli A, Bencivenga S, Giannico MB, Lanzillo C, Maresca L, Petroni R, Penco M, Calò L, Romano S. Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature. Case Rep Cardiol. 2019 Aug 14;2019:5956806. doi: 10.1155/2019/5956806. eCollection 2019. PMID: 31485355; PMCID: PMC6710726.
Copy Download .nbib Format: NLM
E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion.

Oncotarget

Benvegnù S, Wahle T, Dotti CG.
PMID: 29163761
Oncotarget. 2017 Aug 10;8(52):89439-89450. doi: 10.18632/oncotarget.20143. eCollection 2017 Oct 27.

Altered processing of the Amyloid Precursor Protein (APP) is a well-recognized central pathogenic mechanism in Alzheimer's Disease (AD), and regulation of APP processing is a major focus of research in the AD field. However, how age-associated cellular and molecular...

Cite
Benvegnù S, Wahle T, Dotti CG. E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion. Oncotarget. 2017;8(52):89439-89450doi: 10.18632/oncotarget.20143.
Benvegnù, S., Wahle, T., & Dotti, C. G. (2017). E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion. Oncotarget, 8(52), 89439-89450. https://doi.org/10.18632/oncotarget.20143
Benvegnù, Stefano, et al. "E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion." Oncotarget vol. 8,52 (2017): 89439-89450. doi: https://doi.org/10.18632/oncotarget.20143
Benvegnù S, Wahle T, Dotti CG. E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion. Oncotarget. 2017 Aug 10;8(52):89439-89450. doi: 10.18632/oncotarget.20143. eCollection 2017 Oct 27. PMID: 29163761; PMCID: PMC5685682.
Copy Download .nbib Format: NLM
Autoimmune Abnormalities of Postpartum Thyroid Diseases.

Frontiers in endocrinology

Di Bari F, Granese R, Le Donne M, Vita R, Benvenga S.
PMID: 28751877
Front Endocrinol (Lausanne). 2017 Jul 13;8:166. doi: 10.3389/fendo.2017.00166. eCollection 2017.

The year following parturition is a critical time for the

Cite
Di Bari F, Granese R, Le Donne M, et al. Autoimmune Abnormalities of Postpartum Thyroid Diseases. Front Endocrinol (Lausanne). 2017;8:166doi: 10.3389/fendo.2017.00166.
Di Bari, F., Granese, R., Le Donne, M., Vita, R., & Benvenga, S. (2017). Autoimmune Abnormalities of Postpartum Thyroid Diseases. Frontiers in endocrinology, 8166. https://doi.org/10.3389/fendo.2017.00166
Di Bari, Flavia, et al. "Autoimmune Abnormalities of Postpartum Thyroid Diseases." Frontiers in endocrinology vol. 8 (2017): 166. doi: https://doi.org/10.3389/fendo.2017.00166
Di Bari F, Granese R, Le Donne M, Vita R, Benvenga S. Autoimmune Abnormalities of Postpartum Thyroid Diseases. Front Endocrinol (Lausanne). 2017 Jul 13;8:166. doi: 10.3389/fendo.2017.00166. eCollection 2017. PMID: 28751877; PMCID: PMC5507951.
Copy Download .nbib Format: NLM
The various faces of hyperthyroidism.

Journal of clinical & translational endocrinology

Koch CA, Vita R, Benvenga S.
PMID: 32632358
J Clin Transl Endocrinol. 2020 Jun 05;20:100229. doi: 10.1016/j.jcte.2020.100229. eCollection 2020 Jun.

No abstract available.

Cite
Koch CA, Vita R, Benvenga S. The various faces of hyperthyroidism. J Clin Transl Endocrinol. 2020;20:100229doi: 10.1016/j.jcte.2020.100229.
Koch, C. A., Vita, R., & Benvenga, S. (2020). The various faces of hyperthyroidism. Journal of clinical & translational endocrinology, 20100229. https://doi.org/10.1016/j.jcte.2020.100229
Koch, Christian A, et al. "The various faces of hyperthyroidism." Journal of clinical & translational endocrinology vol. 20 (2020): 100229. doi: https://doi.org/10.1016/j.jcte.2020.100229
Koch CA, Vita R, Benvenga S. The various faces of hyperthyroidism. J Clin Transl Endocrinol. 2020 Jun 05;20:100229. doi: 10.1016/j.jcte.2020.100229. eCollection 2020 Jun. PMID: 32632358; PMCID: PMC7274125.
Copy Download .nbib Format: NLM
Environmental Issues in Thyroid Diseases.

Frontiers in endocrinology

Ferrari SM, Fallahi P, Antonelli A, Benvenga S.
PMID: 28373861
Front Endocrinol (Lausanne). 2017 Mar 20;8:50. doi: 10.3389/fendo.2017.00050. eCollection 2017.

Environmental factors are determinant for the appearance of autoimmune thyroid diseases (AITD) in susceptible subjects. Increased iodine intake, selenium, and vitamin D deficiency, exposure to radiation, from nuclear fallout or due to medical radiation, are environmental factors increasing AITD....

Cite
Ferrari SM, Fallahi P, Antonelli A, et al. Environmental Issues in Thyroid Diseases. Front Endocrinol (Lausanne). 2017;8:50doi: 10.3389/fendo.2017.00050.
Ferrari, S. M., Fallahi, P., Antonelli, A., & Benvenga, S. (2017). Environmental Issues in Thyroid Diseases. Frontiers in endocrinology, 850. https://doi.org/10.3389/fendo.2017.00050
Ferrari, Silvia Martina, et al. "Environmental Issues in Thyroid Diseases." Frontiers in endocrinology vol. 8 (2017): 50. doi: https://doi.org/10.3389/fendo.2017.00050
Ferrari SM, Fallahi P, Antonelli A, Benvenga S. Environmental Issues in Thyroid Diseases. Front Endocrinol (Lausanne). 2017 Mar 20;8:50. doi: 10.3389/fendo.2017.00050. eCollection 2017. PMID: 28373861; PMCID: PMC5357628.
Copy Download .nbib Format: NLM
Screening for drugs potentially interfering with MCT8-mediated T.

Journal of endocrinological investigation

Di Cosmo C, De Marco G, Agretti P, Ferrarini E, Dimida A, Falcetta P, Benvenga S, Vitti P, Tonacchera M.
PMID: 34850364
J Endocrinol Invest. 2021 Nov 30; doi: 10.1007/s40618-021-01711-4. Epub 2021 Nov 30.

BACKGROUND: Monocarboxylate transporter 8 (MCT8) is the first thyroid hormone transporter that has been linked to a human disease. Besides genetic alterations other factors might impair MCT8 activity.AIM: This study aimed at investigating whether some common drugs having a...

Cite
Di Cosmo C, De Marco G, Agretti P, et al. Screening for drugs potentially interfering with MCT8-mediated T. J Endocrinol Invest. 2021;doi: 10.1007/s40618-021-01711-4.
Di Cosmo, C., De Marco, G., Agretti, P., Ferrarini, E., Dimida, A., Falcetta, P., Benvenga, S., Vitti, P., & Tonacchera, M. (2021). Screening for drugs potentially interfering with MCT8-mediated T. Journal of endocrinological investigation, . https://doi.org/10.1007/s40618-021-01711-4
Di Cosmo, C, et al. "Screening for drugs potentially interfering with MCT8-mediated T." Journal of endocrinological investigation vol. (2021). doi: https://doi.org/10.1007/s40618-021-01711-4
Di Cosmo C, De Marco G, Agretti P, Ferrarini E, Dimida A, Falcetta P, Benvenga S, Vitti P, Tonacchera M. Screening for drugs potentially interfering with MCT8-mediated T. J Endocrinol Invest. 2021 Nov 30; doi: 10.1007/s40618-021-01711-4. Epub 2021 Nov 30. PMID: 34850364.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 95 entries